John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 25,000 shares at $51.35 ($1.3M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $1.3M DMTK by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DMTK | SELL | 2022-03-15 | $19K | — | Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |